Skip to main content

Closed

CDXS: Codexis, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-15.4% / yr

Operating margin-33.2%

ROIC-22.0%

Financially safe

Stretched

Debt / equity1.69×

Interest coverage-20.0×

Current ratio5.36×

Codexis, Inc.

CDXSNASDAQ Global Select·USD·Closed

Codexis, Inc.

CDXSNASDAQ·USD·Closed

$1.40

−5.41%

$1.40

−$0.08 (5.41%)

52W Range

15thpctl

Volume

1.00×avg

Mkt Cap

127.19MUSD

P/E

-4.0TTM

Div Yield

–ann

52W Range

15thpctl

Volume

1.00×avg

Market Cap

127.19MUSD

P/E Ratio

-4.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings